1. Strategies to investigate migration and metastases in thyroid cancer
   Daniel M. Chopyk et al, 2024, Current Opinion in Endocrine and Metabolic Research CrossRef
2. Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer
   Luis F. Flores et al, 2021, Cells CrossRef
3. LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway
   Ding Li et al, 2022, Bioengineered CrossRef
4. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy
   Yangyang Guo et al, 2023, Frontiers in Immunology CrossRef
5. Fibroblasts as Turned Agents in Cancer Progression
   Robert Wieder, 2023, Cancers CrossRef
6. Elevation of LEM Domain Containing 1 Predicts Poor Prognosis of NSCLC Patients and Triggers Malignant Stemness and Invasion of NSCLC Cells by Stimulating PI3K/AKT Pathway
   Li Li et al, 2024, Current Molecular Medicine CrossRef
7. LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer
   Xiangling Li et al, 2023, Cancers CrossRef
8. LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway
   Xiang Cao et al, 2022, Bioengineered CrossRef
9. Expression profiling and bioinformatics analysis of serum exosomal circular RNAs in lymph node metastasis of papillary thyroid carcinoma
   Huiyong Peng et al, 2024, The Journal of Biomedical Research CrossRef